Target intelligence / Profile preview

Ribosomal protein L29 pseudogene 4 (RPL29P4)

Target
RPL29P4
Molecular classification
Pseudogene
01

Overview

RPL29P4 is a pseudogene derived from the ribosomal protein L29 (RPL29) gene. Pseudogenes are DNA sequences that resemble functional genes but have lost their protein-coding ability through evolutionary processes. They are typically characterized by the presence of stop codons, frameshifts, or other mutations that prevent them from producing functional proteins. The functional parent gene, RPL29, encodes a component of the 60S ribosomal subunit that is essential for protein synthesis. RPL29 belongs to the L29E family of ribosomal proteins and serves as both a structural component of ribosomes and a peripheral membrane protein that can bind heparin. The functional RPL29 protein plays crucial roles in ribosome biogenesis, translational control, and has been implicated in various cellular processes including p53-mediated stress responses and cancer progression. However, RPL29P4, being a pseudogene, does not produce a functional protein and therefore lacks therapeutic relevance. As is typical for ribosomal protein genes, multiple processed pseudogenes of RPL29 are dispersed throughout the human genome, with RPL29P4 being one of these non-functional copies. The pseudogene designation makes RPL29P4 unsuitable as a therapeutic target, as it does not encode a functional protein that could be modulated by drugs or other therapeutic interventions.

Other names
RPL29P3RPL29_6_745bA632C17A.1
02

Mechanism of action

Not applicable (pseudogene)

03

Biological functions

None (pseudogenes are generally non-functional)
04

Disease associations

None directly established
05

Safety considerations

Not applicable
06

Interacting drugs

None identified
07

Biomarkers

None established

Beyond the preview

Go deeper on Ribosomal protein L29 pseudogene 4 (RPL29P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L29 pseudogene 4 (RPL29P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call